HUMAN MONOCLONAL ANTIBODIES TO TNF-? — AGENT OF CHOICE IN TREATMENT OF SEVERE JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS

The article presents a case report of an early debut and severe clinical course of juvenile rheumatoid arthritis with eyes’ lesion. Authors describe successful administration of human monoclonal antibodies to tumor necrotizing factor (TNF) — adalimumab. In 2 weeks of treatment the morning joint stif...

Full description

Bibliographic Details
Main Authors: A.O. Lisitsyn, E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, R.V. Denisova, N.А. Karagulyan, A.M. Chomachidze, K.B. Isaeva
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-05-01
Series:Вопросы современной педиатрии
Online Access:https://vsp.spr-journal.ru/jour/article/view/906